Monitored theme · Healthtech
AI in Healthcare and Drug Discovery
Monitored since January 2017 · 131 temporal technology analyses
TAIME Score over the years
Yearly average of the TAIME Score across published temporal technology analyses. Only years with data for this theme are shown.
Latest TAIME Score
61/100
in the October 2026 analysis
| Year | TAIME Score | Analyses |
|---|---|---|
| 2017 | 69 | 8 |
| 2018 | 70 | 11 |
| 2019 | 72 | 12 |
| 2020 | 72 | 17 |
| 2021 | 73 | 18 |
| 2022 | 70 | 17 |
| 2023 | 75 | 17 |
| 2024 | 78 | 16 |
| 2025 | 81 | 9 |
| 2026 | 73 | 8 |
From the latest analysis · October 2026
Healthcare AI Shifts From Pilots to Governed Workflows Across Screening, Documentation, Staffing and Drug Discovery
Healthcare AI is spreading across the whole value chain at once: mammography support, clinician documentation, internal hiring, pharma evidence synthesis and drug discovery. The binding constraint is no longer capability but trust.
The full analysis of this theme is in the TAIME archive
The theme trajectory, the reading of the current moment, the implications for the organization and the strategic recommendation are available with an account. The Free account opens 1 full analysis per month. Essential gives access to 100% of the archive, with 10+ years of memory.